Among highly selected patients with stage IIIB non-small cell lung cancer (NSCLC), surgical resection appears to improve overall survival when used as a part of multimodality therapy. NSCLC patients who underwent definitive chemoradiation had an average overall survival of 16.3 months, compared with an average of 25.9 months for those who underwent chemotherapy, radiation, and surgical intervention in any sequence.
May 30, 2012
February 22, 2013
January 31, 2012
- AACR-2020The American Association for Cancer Research is the world's oldest and largest professional association related to cancer research.
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.